XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Oxaliplatin
Related studies linked through entity extraction aliases.
Study of Neoadjuvant CT With Selective Radiotherapy in Patients With Intermediate-Risk Cancer Rectum
- Status
- COMPLETED
- Phase
- PHASE2
Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin
- Status
- UNKNOWN
- Phase
- PHASE2
Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Bevacizumab (Avastin) in Participants With Newly Diagnosed Locally Advanced Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of IMC-1121B (Ramucirumab) in Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Aflibercept And Modified FOLFOX6 As First-Line Treatment In Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction
- Status
- COMPLETED
- Phase
- PHASE2
Exploratory Study Of The ERCC-1 Gene
- Status
- COMPLETED
- Phase
- NA
Study of IMC-11F8 in Participants With Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Bevacizumab, Capecitabine and Radiation Therapy With or Without Oxaliplatin Locally Advanced Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel + Oxaliplatin + S-1 in Potentially Operable Gastric or Gastroesophageal Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the Liver
- Status
- COMPLETED
- Phase
- PHASE2
Patients Who Have Failed First Line Treatment for Locally Advanced and/or Metastatic Cervical Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Avastin (Bevacizumab) in Combination With mFOLFOX-6 or FOLFOXIRI in Patients With Metastatic Colorectal Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Systemic Chemotherapy With or Without Intraperitoneal Chemohyperthermia in Treating Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Chemotherapy and Radiation Therapy Before Surgery Followed by Capecitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3